Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Evaluation of ventricular function with first-pass iridium-191m radionuclide angiocardiography

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5601920
Iridium-191m would appear to be a highly useful agent for first-pass radionuclide angiocardiography (FPNA), with its very short half-life (4.96 sec), dual photopeaks (65 and 129 keV), and high injectable activity levels (greater than 100 mc). In order to compare /sup 191m/Ir FPNA to current methods used to define cardiac function, 20 patients referred for cardiac catheterization were studied. Count rate data, right ventricular (RV), and left ventricular ejection fraction (LVEF), LV and diastolic volume (EDV), and end diastolic long axis (AXIS) were evaluated. Count rate data using /sup 191m/Ir FPNA was consistently better than similar data obtained by /sup 99m/Tc FPNA. There were acceptable correlations between /sup 191m/Ir and /sup 99m/Tc FPNA RVEF (r = 0.848), /sup 191m/Ir FPNA and contrast angiography LVEF (r = 0.944), LVEDV (r = 0.917), and LV AXIS (r = 0.866). The data thus suggest that /sup 191m/Ir FPNA has great potential in the evaluation of cardiac function.
Research Organization:
Beilinson Medical Center, Petach Tikva (Israel)
OSTI ID:
5601920
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 30:4; ISSN JNMEA
Country of Publication:
United States
Language:
English